OP0203 Orally-administered CCR1 antagonist CCX354-C in a...

Annals of the Rheumatic Diseases 2013 / 06 Vol. 71; Iss. Suppl 3

OP0203 Orally-administered CCR1 antagonist CCX354-C in a phase 2 rheumatoid arthritis study:

Tak, P.P., Balanescu, A., Tseluyko, V., Bojin, S., Drescher, E., Dairaghi, D., Miao, S., Marchesin, V., Jaen, J., Schall, T.J., Bekker, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
71
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2012-eular.1886
Date:
June, 2013
File:
PDF, 186 KB
english, 2013
Conversion to is in progress
Conversion to is failed